Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-01 Sale |
2020-12-03 4:05 pm |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
91,812 | $27.04 | $2,482,309 | 49,688 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-04 Option Award |
2022-02-08 9:30 pm |
N/A 2032-02-03 |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
120,000 | $0 | 120,000 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:30 pm |
N/A 2032-02-03 |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
175,000 | $0 | 175,000 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:30 pm |
N/A 2032-02-03 |
Seres Therapeutics Inc. | MCRB | Arkowitz David See Remarks |
190,000 | $0 | 190,000 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:30 pm |
N/A 2032-02-03 |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. President, CEO |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:30 pm |
N/A 2032-02-03 |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
130,000 | $0 | 130,000 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:30 pm |
N/A 2032-02-03 |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
175,000 | $0 | 175,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:31 pm |
N/A 2031-06-15 |
Seres Therapeutics Inc. | MCRB | Biondi Paul Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:30 pm |
N/A 2031-06-15 |
Seres Therapeutics Inc. | MCRB | Berenson Stephen Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:30 pm |
N/A 2031-06-15 |
Seres Therapeutics Inc. | MCRB | Kender Richard N Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:30 pm |
N/A 2031-06-15 |
Seres Therapeutics Inc. | MCRB | Dere Willard H Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:30 pm |
N/A 2031-06-15 |
Seres Therapeutics Inc. | MCRB | Graves Kurt Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:30 pm |
N/A 2031-06-15 |
Seres Therapeutics Inc. | MCRB | Ausiello Dennis A Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:30 pm |
N/A 2031-06-15 |
Seres Therapeutics Inc. | MCRB | Behar Gregory Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:30 pm |
N/A 2031-06-15 |
Seres Therapeutics Inc. | MCRB | Zausner Meryl Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-01 9:25 pm |
N/A 2031-05-31 |
Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer |
275,000 | $0 | 275,000 (Direct) |
View |
Ownership |
2021-06-01 9:14 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer |
0 | $0 | 2,000 (Direct) |
View |
| 2021-05-17 Other |
2021-05-19 7:05 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. AFEYAN NOUBAR 10% Owner |
295,171 | $0 | 15,049,991 (Indirect) |
View |
| 2021-02-04 Option Award |
2021-02-08 6:55 pm |
N/A 2031-02-03 |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 6:55 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Chapman Marcus See Remarks |
36,000 | $0 | 36,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 6:53 pm |
N/A 2031-02-03 |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
110,000 | $0 | 110,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 6:51 pm |
N/A 2031-02-03 |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
90,000 | $0 | 90,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 6:50 pm |
N/A 2031-02-03 |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. President, CEO |
350,000 | $0 | 350,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 6:47 pm |
N/A 2031-02-03 |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
130,000 | $0 | 130,000 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 4:05 pm |
2016-09-19 2024-08-06 |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
79,812 | $0 | 49,688 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 4:05 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
26,000 | $0.71 | 49,688 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 4:05 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
27,562 | $6.01 | 49,688 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 4:05 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
26,250 | $9.89 | 49,688 (Direct) |
View |
| 2020-11-23 Other |
2020-11-25 6:02 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Berenson Stephen Director |
3,589 | $0 | 7,178 (Direct) |
View |
| 2020-11-23 Other |
2020-11-25 6:00 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. Flagship Pioneering Inc. Flagship Pioneering Fund VI General Partner LLC Flagship Pioneering Fund VI L.P. AFEYAN NOUBAR 10% Owner |
7,907,179 | $0 | 11,018,191 (Indirect) |
View |
| 2020-10-19 Option Award |
2020-10-21 5:02 pm |
N/A 2030-10-18 |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
200,000 | $0 | 200,000 (Direct) |
View |
| 2020-06-29 Option Award |
2020-07-01 4:07 pm |
N/A 2030-06-28 |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
300,000 | $0 | 300,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-22 4:18 pm |
N/A 2030-06-17 |
Seres Therapeutics Inc. | MCRB | Biondi Paul Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-22 4:15 pm |
N/A 2030-06-17 |
Seres Therapeutics Inc. | MCRB | Ausiello Dennis A Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-22 4:13 pm |
N/A 2030-06-17 |
Seres Therapeutics Inc. | MCRB | Berenson Stephen Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-22 4:12 pm |
N/A 2030-06-17 |
Seres Therapeutics Inc. | MCRB | Graves Kurt Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-22 4:12 pm |
N/A 2030-06-17 |
Seres Therapeutics Inc. | MCRB | Zausner Meryl Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-22 4:11 pm |
N/A 2030-06-17 |
Seres Therapeutics Inc. | MCRB | Kender Richard N Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-22 4:11 pm |
N/A 2030-06-17 |
Seres Therapeutics Inc. | MCRB | Dere Willard H Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-22 4:09 pm |
N/A 2030-06-17 |
Seres Therapeutics Inc. | MCRB | Behar Gregory Director |
30,000 | $0 | 30,000 (Direct) |
View |